Stay updated on GABA-A Targeting in ASD Clinical Trial
Sign up to get notified when there's something new on the GABA-A Targeting in ASD Clinical Trial page.
Latest updates to the GABA-A Targeting in ASD Clinical Trial page
- Check5 days agoNo Change Detected
- Check12 days agoChange DetectedRevision updated from v3.2.0 to v3.3.2; no study content or eligibility criteria appear to be changed.SummaryDifference0.1%
- Check19 days agoChange DetectedA government funding status notice informing users about potential delays in updates and inquiries was removed from this page.SummaryDifference0.4%
- Check34 days agoChange DetectedNew screenshots show a redesigned layout and styling of the Study Details page, with no changes to core study information such as the title, status, locations, eligibility criteria, or primary outcomes. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.5%
- Check62 days agoChange DetectedAdded a government-operating-status notice and a version bump to v3.2.0; removed the previous version label v3.1.0.SummaryDifference5%
- Check69 days agoChange DetectedVersion bumped to v3.1.0 and several safety-related sections (Drug Safety, Counterfeit Drugs, Pharmaceutical Preparations, Substandard Drugs) removed; previous v3.0.2 reference removed as part of the update.SummaryDifference0.6%
- Check84 days agoChange DetectedRevision updated from v3.0.1 to v3.0.2. The 'Back to Top' element was removed.SummaryDifference0.3%
Stay in the know with updates to GABA-A Targeting in ASD Clinical Trial
Enter your email address, and we'll notify you when there's something new on the GABA-A Targeting in ASD Clinical Trial page.